Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma. / Fridthjof, Katrine S; Kampmann, Peter; Dünweber, Anne; Gørløv, Jette S; Nexø, Connie; Friis, Lone S; Nørskov, Kristina H; Welinder, Pernille C; Moser, Claus; Kjeldsen, Lars; Møller, Tom.
In: British Journal of Haematology, Vol. 181, No. 5, 2018, p. 637-641.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma
AU - Fridthjof, Katrine S
AU - Kampmann, Peter
AU - Dünweber, Anne
AU - Gørløv, Jette S
AU - Nexø, Connie
AU - Friis, Lone S
AU - Nørskov, Kristina H
AU - Welinder, Pernille C
AU - Moser, Claus
AU - Kjeldsen, Lars
AU - Møller, Tom
N1 - © 2018 John Wiley & Sons Ltd.
PY - 2018
Y1 - 2018
N2 - Based on experience with comprehensive patient involvement, we present data from implementation of portable, programmable infusion pumps (PPP) for home-based chemotherapy administration in patients with acute leukaemia and in lymphoma patients receiving (carmustine, etoposide, cytarabine, melphalan) BEAM regimen. Data from 84 patients, receiving 177 cycles of PPP administered chemotherapy, showed convincing safety with minor equipment errors encountered and with high patient satisfaction. In-hospital days could be reduced with 52% out of a total of 1197 treatment days. Homebased PPP has several advantages from a patient perspective and furthermore frees up in-hospital beds for patients in need of them.
AB - Based on experience with comprehensive patient involvement, we present data from implementation of portable, programmable infusion pumps (PPP) for home-based chemotherapy administration in patients with acute leukaemia and in lymphoma patients receiving (carmustine, etoposide, cytarabine, melphalan) BEAM regimen. Data from 84 patients, receiving 177 cycles of PPP administered chemotherapy, showed convincing safety with minor equipment errors encountered and with high patient satisfaction. In-hospital days could be reduced with 52% out of a total of 1197 treatment days. Homebased PPP has several advantages from a patient perspective and furthermore frees up in-hospital beds for patients in need of them.
U2 - 10.1111/bjh.15249
DO - 10.1111/bjh.15249
M3 - Journal article
C2 - 29676445
VL - 181
SP - 637
EP - 641
JO - British Journal of Haematology
JF - British Journal of Haematology
SN - 0007-1048
IS - 5
ER -
ID: 215139452